| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000028609 |
| Receipt No. | R000032745 |
| Scientific Title | Investigation of psychological and physiological effects by suction of smell of the carbonated soft drink |
| Date of disclosure of the study information | 2017/08/09 |
| Last modified on | 2020/10/06 (Ver. 3) |
| Basic information | ||
| Public title | Investigation of psychological and physiological effects by suction of smell of the carbonated soft drink | |
| Acronym | Investigation of psychological and physiological effects by suction of smell of the carbonated soft drink | |
| Scientific Title | Investigation of psychological and physiological effects by suction of smell of the carbonated soft drink | |
| Scientific Title:Acronym | Investigation of psychological and physiological effects by suction of smell of the carbonated soft drink | |
| Region |
|
|
| Condition | ||
| Condition | Healthy women | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Scientific verification of effects of smell of the carbonated soft drink to mind and body. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | 1.Evaluation of autonomic nervous system
2.Evaluation of parasympathetic nervous system |
| Key secondary outcomes | 1. A self-report instrument to measure multiple mood states
2.Visual analog scale questionnaire of feeling |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Self control |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | At rest testing.-Suction of control food for 2 min, then testing.-2 min rest.-Suction of test food for 2 min, then testing. | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Female | |||
| Key inclusion criteria | 1. Females aged 30 to 45 years old who live near Tokyo.
2. Subjects who don't come with their child or children on the day of clinical test. 3. Subjects who show understanding of the clinical study procedures and agreement with participating the study by written informed consent prior to the study. 4. Subjects who aren't bad at carbonated soft drinks. 5. Subjects who don't request disclosing of individual test results. |
|||
| Key exclusion criteria | 1. Subjects who have smoking habit.
2. Subjects who are cold-sensitive constitution. (including subjects like that who feel cold on their hands and foots even in summer) 3. Subjects who are currently receiving medication due to treatment of disease. 4. In a past month, subjects who have had custom of taking or applying medicine for the treatment of diseases. 5. Subjects who have previous and/or current medical history of serious disease in liver, kidney, heart, lung and/or blood. 6. Subjects who drink alcohol a lot. 7. Subjects who are aware their menopause symptom. 8. Pregnant or expected pregnant, or lactating women. 9. Subjects who have symptom of dermatologic disease such as atopic dermatitis. 10. Subjects who have undergone surgery on investigation objective portion within the past 6 months. 11. Subjects who are participating the other clinical tests of medicines or foods. Subjects who participated other clinical tests of medicines or foods within a month prior to the current study. 12. Subjects who themselves and/or their family are working for a company that develops and/or manufactures beverage. 13. Other who is determined ineligible by investigator. |
|||
| Target sample size | 21 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | ASAHI SOFT DRINKS CO.,LTD. | ||||||
| Division name | Products Research & Development Laboratory, Research & Development Headquarters | ||||||
| Zip code | 302-0106 | ||||||
| Address | 1-21, MIDORI 1-CHOME, MORIYA-SHI, IBARAKI | ||||||
| TEL | 0297-46-1531 | ||||||
| toshiyuki.kai.a@asahiinryo.co.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | CPCC Company Limited | ||||||
| Division name | Planning & Sales Department | ||||||
| Zip code | 101-0047 | ||||||
| Address | 4F Chusin Building, 3-3-5 Uchikanda Chiyoda-ku, Tokyo 101-0047, JAPAN | ||||||
| TEL | 03-5297-3112 | ||||||
| Homepage URL | |||||||
| cpcc-contact@cpcc.co.jp | |||||||
| Sponsor | |
| Institute | CPCC Company Limited |
| Institute | |
| Department | |
| Funding Source | |
| Organization | ASAHI SOFT DRINKS CO., LTD. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Institutional Review Board of Chiyoda Paramedical Care Clinic |
| Address | 2F Chushin Building, 3-3-5 Uchikanda Chiyoda-ku, Tokyo 101-0047, Japan |
| Tel | 03-5297-5548 |
| IRB@cpcc.co.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB | |||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000032745 |